Summary
Flunitrazolam is a novel lesser-known depressant substance of the benzodiazepine class. It has been noted for its unusual potency for a benzodiazepine compound, being active in the low microgram range. This trait is also shared by compounds such as flubromazolam and clonazolam. Similar to flubromazolam, this is an ultra potent benzodiazepine. A dose of about 0.1 mg (100 µg) is equivalent to 10 mg diazepam or 0.25 mg alprazolam.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 0.1-0.2mg | 0.2-0.3mg | 0.3-0.5mg | 0.5mg+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Peak | Offset | After Effects | Total |
|---|---|---|---|---|---|
| Oral | 20-40 min | 1-2 hrs | 2-4 hrs | 1-12 hrs | 240-0 min |
Tolerance
Build-up
develops over 1–4 weeks of daily use; hypnotic tolerance faster than anxiolytic tolerance
Reset
weeks to months depending on half-life and duration of use; taper recommended
Cross-tolerance
Effects
Positive
- Muscle relaxation
- Anxiolytic
- Muscle Relaxant
- Muscle Relaxation
Negative
- Respiratory depression
- Blackouts
- Sedation
- Sleepiness
- Sedative
- Dystaxia
Positive
- Anxiety suppression
- Euphoria
Negative
- Amnesia
- Motor control loss
- Delusions of sobriety
- Compulsive redosing
- Thought deceleration
- Emotionality suppression
- Dizziness
- Memory suppression
Positive
- Increased libido
- Appetite enhancement
Negative
- Disinhibition
- Acuity suppression
- Decreased Libido
- Acuity Suppression
- Visual acuity suppression
- Double vision
- Dulled perception
- Perception of bodily heaviness